N-of-One® Interprets 4,000th Sequenced Tumor, Revealing Therapeutic Options Beyond the Standard of Care for More than 70% of Cancer Patients

  • Posted by 3mediaweb
  • On August 26, 2013
  • 0 Comments
—N-of-One® achieved industry milestone in clinical interpretation as provider to Foundation Medicine, Inc., Fox Chase Cancer Center and other partners— —N-of-One® interpretation provides the critical link between next-generation sequencing data and the clinical insight needed at the point of care — WALTHAM, Mass., August 26, 2013—N-of-One Inc., the leading provider of molecular interpretation and therapeutic […]
Read More
BACK TO
TOP
LEARN
MORE